In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Zealand Pharma nets DKK321mm through its IPO

Executive Summary

After extending the pricing date and lowering the range, Copenhagen-based cardiovascular, gastrointestinal, and metabolic therapeutics developer Zealand Pharma AS has finally netted DKK320.6mm ($58.8mm) through the sale of 4.34mm shares at DKK86 each. The company had planned to raise up to DKK1.1bn by selling 9mm shares at DKK86-90 each.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Large Molecule
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies